23rd annual Wall Street Comes to Washington Health Care Roundtable
from Brookings: Topics – Health at https://brook.gs/2Q9rt0W on October 31, 2018 at 10:40PM
Month: October 2018
23rd annual Wall Street Comes to Washington Health Care Roundtable
from Brookings: Topics – Health at https://brook.gs/2Q9rt0W on October 31, 2018 at 08:26PM
Growing Evidence Supports Best Practices in Palliative Care
from RAND Research Topic: Health and Health Care at http://bit.ly/2CSLTrn on October 31, 2018 at 08:17PM A rapidly aging U.S. population with complex care needs will likely accelerate emphasis on palliative care services. A review of palliative care research found substantial evidence to support clinical practice guidelines and was incorporated into the new edition of […]
Supply-Side Drug Policy in the Presence of Substitutes
from RAND Research Topic: Health and Health Care at http://bit.ly/2P0wJb0 on October 31, 2018 at 08:17PM The recent increase in heroin deaths is primarily fueled by the reformulation of OxyContin.
How do we include health inequality impacts in economic analysis of policy options?
from Centre for Health Economics – Latest news at http://bit.ly/2OglTZ5 on October 31, 2018 at 04:46PM CHE’s latest Policy Briefing written by Brendan Collins, Susan Griffin, Miqdad Asaria, Simon Capewell, James Love-Koh, Chris Kypridemos, Jonathan Pearson-Stuttard, Martin O’Flaherty and Richard Cookson
CancerCostMod: a model of the healthcare expenditure, patient resource use, and patient co-payment costs for Australian cancer patients
from Health Economics Review at http://bit.ly/2RrFlEa on October 31, 2018 at 04:21PM Although cancer survival in general has improved in Australia over the past 30 years, Indigenous Australians, socioeconomically disadvantaged persons, and people living in remote areas still experience poorer …
ISPOR Releases Final Program, Speakers for ISPOR Europe 2018
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2P06HV3 on October 31, 2018 at 04:12PM The International Society for Pharmacoeconomics and Outcomes Research this week announced the final program and speakers for its Nov. 10-14 ISPOR Europe 2018 meeting in Barcelona, Spain. According to a press release, the conference in Europe pulls some 5,000 stakeholders in […]
Pfizer CEO: Business as Normal Come January
from tHEORetically Speaking: The HealthEconomics.Com Blog at https://www.healtheconomics.com/government/pfizer-ceo-business-as-normal-come-january on October 31, 2018 at 03:42PM Pfizer CEO Ian Read says the company will return to “business as normal” and continue with scheduled price increases at the start of 2019, despite pressure from President Donald Trump, FirstWord Pharma reports. The company in July deferred price hikes after […]
“We are fierce, independent thinkers and intelligent”: Social capital and stigma management among mothers who refuse vaccines
from Social Science & Medicine at https://www.sciencedirect.com/science/article/pii/S0277953618306233?dgcid=rss_sd_all on October 31, 2018 at 03:39PM Publication date: Available online 30 October 2018 Source: Social Science & Medicine Author(s): Jennifer A. Reich Abstract Despite measurable benefits of childhood vaccines, mothers with high levels of social privilege are increasingly refusing some or all vaccines for their children. These mothers […]
The effect of school sports facilities on physical activity, health and socioeconomic status in adulthood
from Social Science & Medicine at https://www.sciencedirect.com/science/article/pii/S027795361830621X?dgcid=rss_sd_all on October 31, 2018 at 03:39PM Publication date: Available online 30 October 2018 Source: Social Science & Medicine Author(s): Nicole Black, David Johnston, Carol Propper, Michael Shields Abstract This paper focuses on the long-term impacts of attending a high school with inadequate sports facilities. We use prospective data […]
Judges Shouldn’t Have the Power to Halt Laws Nationwide
from The Incidental Economist at http://bit.ly/2P5lz4Q on October 31, 2018 at 02:00PM That’s the headline to an article of mine, co-authored with Sam Bray of Notre Dame Law School and published today in The Atlantic. We highlight the disquieting possibility that a single district court in Texas might soon enter an injunction prohibiting the enforcement […]
New Study Finds Immigrants Pay More in Private Insurance Premiums Than They Receive In Benefits
from AcademyHealth Blog at http://bit.ly/2OhEGDs on October 31, 2018 at 01:19PM New Study Finds Immigrants Pay More in Private Insurance Premiums Than They Receive In Benefits Published in the October edition of Health Affairs, findings from our study using nationally representative data show that immigrants heavily subsidize private insurance of US-born enrollees and boost profits […]
Life-Saving Data That Is Nowhere To Be Found: Hospitals’ C-section Rates
from THCB at http://bit.ly/2RraKGO on October 31, 2018 at 01:01PM By DANI BRADLEY, MS, MPH The United States is the only developed nation in the world with a steadily increasing maternal mortality rate — and C-sections are to blame. Nearly 32% of babies are born via C-section in the United States, a rate of double […]
EconTrack: The AEA’s Job Market Information Board
from Market Design at http://bit.ly/2Q9WGkW on October 31, 2018 at 12:39PM The AEA has launched a job market information board, which will collect information about the progress of interviews and flyouts for (I imagine) jobs that advertise in the JOE. Here it is: EconTrack: The AEA’s Job Market Information Board, and the headings for the information […]
A Sense of Alarm as Rural Hospitals Keep Closing
from The Incidental Economist at http://bit.ly/2Rwqqc3 on October 31, 2018 at 11:13AM The following originally appeared on The Upshot (copyright 2018, The New York Times Company). Hospitals are often thought of as the hubs of our health care system. But hospital closings are rising, particularly in some communities. “Options are dwindling for many rural families, and remote […]
Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review
from The European Journal of Health Economics at http://bit.ly/2PAupXq on October 31, 2018 at 07:33AM Abstract Background Bone metastases are highly prevalent in breast, prostate, lung and colon cancers. Their symptoms negatively affect quality of life and functionality and optimal management can mitigate these problems. There are two different targeted agents to treat them: bisphosphonates […]
HEDS presentation on Screening for severe combined immunodeficiency: Using probabilistic uncertainty analysis of economic models to assess the reliability of screening policy decisions
from Health Economics and Decision Science Blog @ ScHARR at http://bit.ly/2qi8ING on October 31, 2018 at 07:00AM Professor Jim Chilcott delivered a presentation at the ISNS conference in Bratislava earlier this month. His presentation was titled: Screening for severe combined immunodeficiency: Using probabilistic uncertainty analysis of economic models to assess the reliability of screening policy decisions. The […]
90% of health plans think the use of alternative payment models will increase in the coming years
from Healthcare Economist at http://bit.ly/2AEjJyZ on October 31, 2018 at 06:31AM A recent report from the Health Care Payment Learning and Action Network (HCP LAN) examines how providers are getting paid in the U.S. today. Traditionally, health care providers (e.g., physicians, hospitals) were paid via fee-for-service (FFS). Fee-for-service means that every time a provider does […]
Contribution of individual COPD assessment test (CAT) items to CAT total score and effects of pulmonary rehabilitation on CAT scores
from Health and Quality of Life Outcomes at http://bit.ly/2CQwZC6 on October 31, 2018 at 06:21AM The COPD Assessment Test (CAT) contains eight items (cough, phlegm, chest tightness, breathlessness, limited activities, confidence leaving home, sleeplessness and energy). The current study aimed 1) to better…
FirstWord Report Looks at Pharma Perspective on RWD
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2qkP4ka on October 30, 2018 at 05:22PM A FirstWord report from March 2017 delves into the pharma perspective on real-world data, and includes interviews with seven senior decision-markers involved in RWD and real-world evidence. The report, “Real World Data Capabilities: Benchmarking Pharma Companies,” offers an overview of RWD, […]
Article: Plans to Reduce Drug Prices Could Limit Treatments to Patients
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2Q2PZRC on October 30, 2018 at 04:52PM While some companies are working to implement new plans to pull down drug prices, some which fail to consider “a wide variety of factors in value assessment” could spell access troubles for patients in need, according to an article published on […]
Facts, Conclusions, and More Questions on the Road to Solving Disparities
from THCB at http://bit.ly/2Jpohf6 on October 30, 2018 at 01:47PM By SCOTT COOK, PhD We tested whether new payment mechanisms could be harnessed in health care delivery reform to reduce health and health care disparities. Here’s what we found. First, there were facts that couldn’t be ignored: #1: Children in rural Oregon on Medicaid suffered […]
Parental warmth and flourishing in mid-life
from Social Science & Medicine at http://bit.ly/2ESmsZx on October 30, 2018 at 01:18PM Publication date: Available online 30 October 2018 Source: Social Science & Medicine Author(s): Ying Chen, Laura D. Kubzansky, Tyler J. VanderWeele Abstract Objective This study examined the longitudinal association between parental warmth and offspring flourishing in mid-life. We also considered associations between […]
Step by Step toward Medical and Addiction Care Integration
from AcademyHealth Blog at http://bit.ly/2AC5wm3 on October 30, 2018 at 01:14PM Step by Step toward Medical and Addiction Care Integration In the course of just a few decades, routine medical care has gone from being delivered primarily through community-based practices to being situated most often in large, corporately organized entities — as within those large […]
The (hot) job market for “Digitization Economists”
from Market Design at http://bit.ly/2AyJOiD on October 30, 2018 at 12:22PM HBS interviews Mike Luca on the market for new economists (and his recent paper with Susan Athey): Hunting for a Hot Job in High Tech? Try ‘Digitization Economist’ “Some 50 tech companies “have been snapping up economists at a remarkable scale,” says Michael Luca, […]
Effects of Medication-Assisted Treatment (MAT) for Opioid Use Disorder on Functional Outcomes
from RAND Research Topic: Health and Health Care at http://bit.ly/2qiGF0s on October 30, 2018 at 12:18PM This systematic review synthesizes evidence on the effects of medication-assisted treatment for opioid use disorder on functional outcomes, including cognitive, physical, occupational, social/behavioral, and neurological function.
Los Angeles County’s Mental Health Full Service Partnerships Yield Cost Savings
from RAND Research Topic: Health and Health Care at http://bit.ly/2OVTJHY on October 30, 2018 at 12:18PM RAND estimated government spending and cost savings associated with outcomes targeted by Full Service Partnership programs in Los Angeles County: homelessness, criminal justice detention, health care (inpatient and outpatient), and employment.
Evaluating Cost Savings Associated with Los Angeles County’s Mental Health Full Service Partnerships
from RAND Research Topic: Health and Health Care at http://bit.ly/2CRTd6N on October 30, 2018 at 12:18PM This report estimates government spending and cost savings associated with outcomes targeted by Full Service Partnership programs in Los Angeles County: homelessness, criminal justice detention, health care (inpatient and outpatient), and employment.
NHS and the Budget 2018
from Centre for Health Economics – Latest news at http://bit.ly/2qje0s9 on October 30, 2018 at 11:53AM Maria Goddard writes for The Conversation
Nonprofit Looks to Midterms to Combat High Drug Prices
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2CPdhXg on October 30, 2018 at 08:48AM Patients for Affordable Drugs is looking to the midterms to spread awareness about high drug prices, according to The Guardian, backing candidates who have a history of pushing for price decreases. The group’s founder, David Mitchell, who had also been diagnosed […]
Including intangible costs into the cost-of-illness approach: a method refinement illustrated based on the PM 2.5 economic burden in China
from The European Journal of Health Economics at http://bit.ly/2qiWJPP on October 30, 2018 at 08:30AM Abstract The concentrations of particulate matter with aerodynamic diameters less than 2.5 µm (PM2.5) and 10 µm (PM10) is a widespread concern and has been demonstrated for 103 countries. During the past few years, the exposure–response function (ERf) has been widely used […]
ISPOR Europe 2018 Conference to Focus on Improving Healthcare Systems in Europe
from ISPOR News & Press Releases at http://bit.ly/2qjPK9k on October 30, 2018 at 07:36AM More Than 5000 Healthcare Stakeholders Will Convene on 10-14 November 2018 in Barcelona, Spain Lawrenceville, NJ, USA—October 30, 2018—ISPOR, the professional society for health economics and outcomes research (HEOR), released the final program and speakers for its upcoming ISPOR Europe 2018 […]
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data
from PharmacoEconomics at http://bit.ly/2Q6L426 on October 30, 2018 at 06:42AM Abstract Objective We estimated the cost consequence of Italian National Health System (NHS) investment in direct-acting antiviral (DAA) therapy according to hepatitis C virus (HCV) treatment access policies in Italy. Methods A multistate, 20-year time horizon Markov model of HCV liver disease progression was developed. […]
Silencing Noisy Health Care?
from THCB at http://bit.ly/2P1zNUl on October 30, 2018 at 04:23AM By MATTHEW HOLT As you’ve probably heard (enough!) from me and Indu Subaiya over recent months on video, at Health 2.0 or here on THCB, we are finally arriving at the point where health care tech is “flipping the stack” — where we realize that […]
Book Review: Overcharged
from Healthcare Economist at http://bit.ly/2OfkqC8 on October 30, 2018 at 04:11AM In the book Overcharged, authors Charles Silver and David Hyman identify a number of problems with the current health care system. Third party payment under a fee-for-service system means that providers have an incentive to provide more rather than less care. Further, because the […]
ISPOR to Host Webinar Nov. 27
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2CQUTNT on October 30, 2018 at 12:01AM The International Society for Pharmacoeconomics and Outcomes Research is set to host a Nov. 27 webinar titled “Mapping to Estimate Health-State Utility from Non-Preference-Based Outcomes Measures.” To register, click here.
UnitedHealth’s Genoa Acquisition Boosts OptumRx’s Position
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2P1EQnt on October 30, 2018 at 12:01AM UnitedHealth Group’s acquisition of Genoa HealthCare bolsters OptumRx’s competitive position in the pharmacy benefit arena, according to an MMIT report. KPMG’s Ashram Shehata says the purchase strengthen’s UnitedHealth amid huge shifts in the industry, including the CVS-Aetna and Cigna-Express Scripts deals. […]
Genes, Education, and Labor Market Outcomes: Evidence from the Health and Retirement Study
from Health Economics at http://bit.ly/2PtmWtg on October 30, 2018 at 12:21AM Recent advances have led to the discovery of specific genetic variants that predict educational attainment. We study how these variants, summarized as a linear index — known as a polygenic score — are associated with human capital accumulation and labor market outcomes in the […]
Womb at work: the missing impact of maternal employment on newborn health
from Health Economics at http://bit.ly/2zbShGI on October 30, 2018 at 12:21AM Parental leave policies across the globe have become much more generous than they used to be. This is also true for prenatal maternal leave. While this may be costly in the short run, little is known about the effect of maternal employment during pregnancy […]
PhRMA’s Ubl: Trump Drug Pricing Plan Imports ‘Foreign Price Controls’
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2Q5hOZs on October 29, 2018 at 11:31PM PhRMA CEO Stephen Ubl slammed the Trump administration’s latest proposal to combat high drug prices, calling it the importation of “foreign price controls,” PMLiVE reports. The plan, which was unveiled last week, would look to bring the price of drugs covered […]
Health Econ Bot 
You must be logged in to post a comment.